Bovine herpesvirus 4 based vector interaction with liver cells in vitro and in vivo

Journal of Virological Methods

Volumn 136, Issue 1-2, 2006, Pages 126-136

  Donofrio, Gaetano ^a   Martignani, Eugenio ^a   Poli, Enzo ^a   Lange, Claudia ^b   Martini, Filippo Maria ^a   Cavirani, Sandro ^a   Cabassi, Clotilde Silvia ^a   Taddei, Simone ^a   Flammini, Cesidio Filippo ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Bovine herpesvirus 4; Endothelial cells; Infection; Liver; Transduction

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; HERPESVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BOVINE HERPES VIRUS; BOVINE HERPES VIRUS 4; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENE TRANSFER; GENETIC TRANSDUCTION; IN VITRO STUDY; IN VIVO CULTURE; INOCULATION; LIVER CELL; LIVER PARENCHYMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; CELL LINE; ENDOTHELIAL CELLS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPATOCYTES; HERPESVIRUS 4, BOVINE; LIVER; MALE; MICROSCOPY, FLUORESCENCE; RATS; RATS, INBRED BUF; STAINING AND LABELING;

BOVINE HERPESVIRUS 4; RATTUS NORVEGICUS;

EID: 33746038105     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.04.008     Document Type: Article

References (49)

1. Alemany R., Suzuki K., and Curiel D.T. Blood clearance rates of adenovirus type 5 in mice. J. Gen. Virol. 81 (2000) 2605-2609
2. Alexander M.Y., Brosnan M.J., Hamilton C.A., Fennell J.P., Beattie E.C., Jardine E., Heistad D.D., and Dominiczak A.F. Gene transfer of endothelial nitric oxide synthase but not Cu/Zn superoxide dismutase restores nitric oxide availability in the SHRSP. Card. Res. 47 (2000) 609-617
3. Ballestas M.E., Chatis P.A., and Kaye K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284 (1999) 641-644
4. Bartha A., Fadol A.M., Liebermann H., Ludwig H., Mohanty S.B., Osorio F.A., Reed D.E., Storz J., Straub O.C., Van der Maaten M.J., and Wellermans G. Problems concerning the taxonomy of the "Movar-Type" bovine herpesvirus. Intervirology 28 (1987) 1-7
5. Brunner K.T., Hurez D., McKluskey R.T., and Benacerras B. Blood clearance of P32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice. J. Immunol. 85 (1960) 99-105
6. Ceserman E., Moore P.S., Rao P.H., Inghirami G., Knowles D.M., and Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86 (1995) 2708-2714
7. Chu Y., Iida S., Lund D.D., Weiss R.M., DiBona G.F., Watanabe Y., Faraci F.M., and Heistad D.D. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in SHR. Circ. Res. 92 (2003) 461-468
8. Decker L.L., Shankar P., Khan G., Freeman R.B., Dezube B.J., Lieberman J., and Thorley-Lawson D.A. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J. Exp. Med. 184 (1996) 283-288
9. Dewals B., Gillet L., Gerdes T., Taracha E.L., Thiry E., and Vanderplasschen A. Antibodies against bovine herpesvirus 4 are highly prevalent in wild African buffaloes throughout eastern and southern Africa. Vet. Microbiol. 110 (2005) 209-220
10. Donofrio G., Cavirani S., and van Santen V.L. Establishment of a cell line persistently infected with bovine herpesvirus 4 using a recombinant virus. J. Gen. Virol. 81 (2000) 1807-1814
11. Donofrio G., Colleoni S., Galli C., Lazzari G., Cavirani S., and Flammini C.F. Susceptibility of bovine mesenchymal stem cells to bovine herpesvirus 4. J. Virol. Methods 127 (2005) 168-170
12. Donofrio G., Grandi G., Cavirani S., Taddei S., and Flammini C.F. Bovine herpesvirus 4 infects differentiated neuronal cells in culture and establish persistent infection upon selection. J. Neurovirol. 10 (2004) 123-130
13. Donofrio G., Cavirani S., Taddei S., and van Santen V.L. Bovine herpesvirus 4 as a gene delivery vector. J. Virol. Methods 101 (2002) 49-61
14. Dubuisson J., Thiry E., Bublot M., Thomas I., van Bressem M.F., Coignoul F., and Pastoret P.P. Experimental infection of bulls with a genital isolate of bovine herpesvirus-4 and reactivation of latent virus with dexamethasone. Vet. Microbiol. 21 (1989) 97-114
15. Egyed L., and Bartha A. PCR studies on the potential sites for latency of BHV-4 in calves. Vet. Res. Commun. 22 (1998) 209-216
16. Flore O., Rafii S., Ely S., O'Leary J.J., Hyjek E.M., and Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394 (1998) 588-592
17. Gillet L., Daix V., Donofrio G., Wagner M., Koszinowski U.H., China B., Ackermann M., Markine-Goriaynoff N., and Vanderplasschen A. Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning. J. Gen. Virol. 86 (2005) 907-917
18. Gillet L., Dewals B., Farnir F., de Leval L., and Vanderplasschen A. Bovine herpesvirus 4 induces apoptosis of human carcinoma cell lines in vitro and in vivo. Cancer Res. 65 (2005) 9463-9472
19. Gillet L., Minner F., Detry B., Farnir F., Willems L., Lambot M., Thiry E., Pastoret P.P., Schynts F., and Vanderplasschen A. Investigation of the susceptibility of human cell lines to bovine herpesvirus 4 infection: demonstration that human cells can support a nonpermissive persistent infection which protects them against tumor necrosis factor alpha-induced apoptosis. J. Virol. 78 (2004) 2336-2347
20. Glorioso J.C., De Luca N.A., and Fink D.J. Development and application of herpes simplex virus vectors for human gene therapy. Annu. Rev. Microbiol. 49 (1995) 675-710
21. Jung J.U., Choi J.K., Ensser A., and Biesinger B. Herpesvirus saimiri as a model for gammaherpesvirus oncogenesis. Semin. Cancer Biol. 9 (1999) 231-239
22. Jung O., Marklund S.L., Geiger H., Pedrazzini T., Busse R., and Brandes R.P. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ. Res. 93 (2003) 622-629
23. Kaiser J. Gene therapy. Panel urges limits on X-SCID trials. Science 307 (2005) 1544-1545
24. Kieff E. Epstein-Barr virus and its replication. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fundamental Virology. third ed. (1996), Lippincott-Raven Publishers, Philadelphia pp. 1109-1162
25. Krogman L.A., and McAdaragh J.P. Recrudescence of bovine herpesvirus-5 in experimentally infected calves. Am. J. Vet. Res. 43 (1982) 336-338
26. Kung S.H., and Medveczky P.G. Identification of a herpesvirus Saimiri cis-acting DNA fragment that permits stable replication of episomes in transformed T cells. J. Virol. 70 (1996) 1738-1744
27. Lange C., Bassler P., Lioznov M.V., Bruns H., Kluth D., Zander A.R., and Fiegel H.C. Liver-specific gene expression in mesenchymal stem cells is induced by liver cells. World J. Gastroenterol. 11 (2005) 4497-4504
28. Lin K.F., Chao L., and Chao J. Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. Hypertension 30 (1997) 307-313
29. Lomonte P., Bublot M., vanSanten V.L., Keil G., Pastoret P.P., and Thiry E. Bovine herpesvirus 4: genomic organization and relationship with two other gammaherpesviruses, Epstein-Barr virus and herpesvirus saimiri. Vet. Microbiol. 53 (1996) 79-89
30. Lupton S., and Levine A.J. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol. Cell. Biol. 5 (1985) 2533-2542
31. Mettenleiter T.C. Glycoprotein gIII deletion mutants of pseudorabies virus are impaired in virus entry. Virology 171 (1989) 623-625
32. Miller G., Heston L., Grogan E., Gradoville L., Rigsby M., Sun R., Shedd D., Kushnaryov V.M., Grossberg S., and Chang Y. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol. 71 (1997) 314-324
33. Moses A.V., Fish K.N., Ruhl R., Smith P.P., Strussenberg J.G., Zhu L., Chandran B., and Nelson J.A. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J. Virol. 73 (1999) 6892-6902
34. Naeem K., Caywood D.D., Goyal S.M., Werdin R.E., and Murtaugh M.P. Persistence of bovid herpesvirus-4 in experimentally inoculated pregnant rabbits. Microbiologica 16 (1993) 87-94
35. Nilsson K. The nature of lymphoid cell lines and their relationship to the virus. In: Epstein M.A., and Achong B.G. (Eds). The Epstein-Barr Virus (1979), Springer-Verlag, Berlin 225-281
36. Nissley S.P., Short P.A., Rechler M.M., Podskalny J.M., and Coon H.G. Proliferation of buffalo rat liver cells in serum-free medium does not depend upon multiplication-stimulating activity (MSA). Cell 11 (1977) 441-446
37. Osorio F.A., Reed D.E., and Rock D.L. Experimental infection of rabbits with bovine herpesvirus-4: acute and persistent infection. Vet. Microbiol. 7 (1982) 503-513
38. Osorio F.A., and Reed D.E. Experimental inoculation of cattle with bovine herpesvirus-4: evidence for a lymphoid-associated persistent infection. Am. J. Vet. Res. 44 (1983) 975-980
39. Osorio F.A., Rock D.L., and Reed D.E. Studies on the pathogenesis of a bovine cytomegalo-like virus in an experimental host. J. Gen. Virol. 66 (1985) 1941-1951
40. Peterson R.B., and Goyal S.M. Propagation and quantitation of animal herpesviruses in eight cell culture systems. Comp. Immunol. Microbiol. Infect. Dis. 11 (1988) 93-98
41. Reddy K.S. Cardiovascular disease in non-Western countries. N. Engl. J. Med. 350 (2004) 2438-2440
42. Thiry E., Bublot M., Dubuisson J., and Pastoret P.P. Bovine herpesvirus-4 (BHV-4) infections of cattle. In: Wittmann G. (Ed). Herpesvirus Diseases of Cattle, Horses and Pigs (1989), Kluwer Academic Publishers, Boston pp. 96-115
43. Truman D., Ludwig H., and Storz J. Bovine herpesvirus type 4: studies on the biology and spread in cattle herds and in insemination bulls. J. Vet. Med. 33 (1986) 485-501 (Series B)
44. Usherwood E.J., Stewart J.P., and Nash A.A. Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice. J. Virol. 70 (1996) 6516-6518
45. Vanderplasschen A., Goltz M., Lyaku J., Benarafa C., Buhk H.J., Thiry E., and Pastoret P.P. The replication in vitro of the gammaherpesvirus bovine herpesvirus 4 is restricted by its DNA synthesis dependence on the S phase of the cell cycle. Virology 213 (1995) 328-340
46. Yates J., Warren N., Reisman D., and Sugden B. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 3806-3810
47. Yates J.L., Warren N., and Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313 (1985) 812-815
48. Zhang L., Dailey P.J., Gettie A., Blanchard J., and Ho D.D. The liver is a major organ for clearing simian immunodeficiency virus in rhesus monkeys. J. Virol. 76 (2002) 5271-5273
49. Zimmermann W., Broll H., Ehlers B., Buhk H.J., Rosenthal A., and Goltz M. Genome sequence of bovine herpesvirus 4, a bovine Rhadinovirus, and identification of an origin of DNA replication. J. Virol. 75 (2001) 1186-1194